Dataset Information


Knockout of EZH2 inhibits the tumorigenicity of human ovarian cancers cells SKOV3 by targeting steroid biosynthesis

ABSTRACT: Ovarian cancer has the highest mortality in gynecologic cancers and most patients are diagnosed in advanced stages. EZH2 has been a major tumor markers and effective therapeutic targets for ovarian cancer, which molecular mechanism remain unclear. The present study was investigated the biological effects on EZH2 knock-out SKOV3 cells in vitro and in vivo experiment, and explore the molecular mechanism by integrated analysis of mRNA-seq and CHIP-seq.
 CRISPR/Cas9 system was used to establish the knock-out EZH2 SKOV3 cells. Protein expression was detected by Western blot. The effect of EZH2 in ovarian cancer was detected by MTT assay, wound scratch assay and Transwell assay, apoptosis assay in vitro and xenograft model in vivo. mRNA-seq and CHIP-seq was used to explore the molecular mechanism of biological function of EZH2. Overall design: mRNA and H3K27me3 profiles of wild type (WT) SKOV3 and SKOV3/sgEZH2 were generated by deep sequencing

INSTRUMENT(S): Illumina HiSeq 2500 (Homo sapiens)

ORGANISM(S): Homo sapiens  


PROVIDER: GSE145692 | GEO | 2020-02-22


Dataset's files

Action DRS
GSE145692_All.HTSeq.counts.txt.gz Txt
Items per page:
1 - 1 of 1

Similar Datasets

2020-01-01 | S-EPMC7591459 | BioStudies
2020-01-01 | S-EPMC7247607 | BioStudies
2018-01-01 | S-EPMC5919713 | BioStudies
1000-01-01 | S-EPMC3879084 | BioStudies
2020-01-01 | S-EPMC7201572 | BioStudies
2020-01-01 | S-EPMC7504643 | BioStudies
2013-01-01 | S-EPMC3648479 | BioStudies
2019-01-01 | S-EPMC6566439 | BioStudies
2020-01-01 | S-EPMC7200223 | BioStudies
2020-01-01 | S-EPMC7443403 | BioStudies